HIV Market Is Progressing Towards A Strong Growth By 2020
For Any Queries Get Solutions With A PDF Sample : http://bit.ly/2fikZLE
Treatments also involve dietary modifications and symptomatic relief of conditions presented during the onset of AIDS. Therapeutic treatment is often costly and requires constant supply of energy compounds (sugar/fat) in order for the patient to maintain a standard daily requirement. The affordability of such treatments is a factor of concern in many developing countries of the world. Furthermore, highest number of HIV-infected people is witnessed in poor countries. There is a majority of the HIV infected population living in sub-Saharan Africa region. Hence, worldwide healthcare companies are ensuring to lower their costs in this region so that they can introduce their products to generic competition.
That said, the market for HIV therapeutics potentially remains in billions, with new patent trials being conducted every year. HIV market therefore remains highly attractive in terms of novel drugs and their impact globally. Asian manufacturers are proving to be a tough competition with their unique patent laws that circumvent patent of essential life saving medicines. The prices too are bound to decrease with the entry of such manufacturers, thereby potentially increasing therapeutics market in terms of volume. The North American HIV market is the highest market globally, by value and occupies more than 50% of the global revenue generated from HIV antiviral; this is followed by the European market at around 30% of the global market. The growth in these regions is mainly attributed to high affordability of drugs along with a range of health insurance coverage. In developing markets of Asia and South America, the leading cause of death is their poor healthcare standards. This along with their population size make for a potentially large market, however unavailability of affordable drugs is often the reason why markets haven’t been proliferated as of yet. On the other hand, the recent growth of market in Asia Pacific is a positive sign for potential manufacturers. The rest of the world also follows a similar pattern like Asia. Overall the Asian, African and South American region contribute less than 20% share in the global HIV market.
Some of the well known companies manufacturing HIV drugs are: Bristol-Myers Squibb Company, ViiV Healthcare (Pfizer Inc.) and GlaxoSmithKline plc, Gilead Sciences Inc., Boehringer Ingelheim (C.H. Boehringer Sohn AG & Ko. KG), F. Hoffmann-La Roche AG, Abbott Laboratories Inc., Janssen Therapeutics, Merck & Co. Inc., Cipla Limited, and others, to name a few.
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Transparency Market Research
90 State Street,
NY - 12207
USA - Canada Toll Free 866-552-3453
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release HIV Market Is Progressing Towards A Strong Growth By 2020 here
News-ID: 384411 • Views: 610
More Releases from Transparecny Market Research
Aluminium Pan Market - Business Strategies With Major Key Players | Groupe SEB, …
Aluminium Pan Market: An Overview The need for low price, strong and lightweight cookware urged the companies to manufacture aluminium pan. The pan is cheap and durable as compared to other pan made from different materials. It is extensively used in household works because of its budget cost and various advantages. Aluminium pan is cost-effective, fire resistant, and is a good conductor of heat. This pan is temperature resistant and does
Hog Production and Pork Market to Reach a Valuation of ~US$ 464 Bn by 2027: Tran …
Hog Production and Pork Market: Introduction A recent study published by Transparency Market Research on the hog production and pork market includes global industry analysis and opportunity assessment for 2019-2027. The global hog production and pork market is expected to be valued at ~US$ ~398 Bn in 2019, which is projected to rise at a CAGR of ~2%, to reach a value of US$ 464 Bn by 2027. Obtain Report Details: https://www.transparencymarketresearch.com/hog-production-pork-market.html Pork
2,3-Butanediol Market 2027 - Demand and Sales Forecasts, Market Share, Market Si …
2,3-Butanediol Market – Production to Move from Pilot Plants to Full-scale The ~3% CAGR of the 2,3-butanediol market during 2019-2027 is emblematic of a nascent phase of the industry, which currently possesses narrow channels of commercialization. To infiltrate proper education regarding the use of this chemical as a precursor, manufacturers are making investments towards the development of pilot plants. View Full Report @ https://www.transparencymarketresearch.com/2-3-butanediol-market.html According to the research, the demand for 2,3-butanediol as
2-Ethylhexanoic Acid Market To Reach US$ 1.46 Bn By 2026
Overview The research report provides valuable insights into demand drivers, geographical outlook, and competitive landscape of the 2-Ethylhexanoic Acid Market for the 2017-2025 forecast period. Further, it throws light on restraints as well discusses opportunities at length that are likely to come to the fore over the forecast period. The analysis thus provided helps Market stakeholders with business planning and to gauge scope of expansion in the 2-Ethylhexanoic Acid Market over
More Releases for HIV
Global HIV Market to 2024
The HIV market was valued at $16bn in 2015 and is forecast to expand at a CAGR of 3.7% between 2015 and 2024, culminating in 2024 global sales of $23bn.The expected arrival of new classes of therapies could result in a paradigm shift in the treatment of HIV treatment. Globally, around 35 million people are infected with HIV. Approximately 3 million people in the U.S and 2.5 million in top 5
HIV Vaccine Market HIV Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: firstname.lastname@example.org or +91-11-47067990 Report Table of Contents Introduction to Human Immunodeficiency Virus (HIV) Vaccines 1.1 Overview 1.2 Antiquity of HIV Vaccine Need for the Development of HIV Vaccine Primer of HIV inside the Body 3.1 Inclusion of HIV Virus into the System 3.2 Interaction of HIV with Host 3.3 Eradication of HIV Virus HIV Vaccine Development Process 4.1 Introduction
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific ways
Global HIV Infection Pipeline Analysis
The discovery of HIV virus, which causes AIDS, dates back to more than 30 years. Currently, there are more than 30 drugs in the market which have been approved by the FDA for the treatment of HIV infection. Consequent to the introduction of retrovirals in 1996, HIV is not considered to be a death sentence anymore. The advancements in this field have led to new drugs being produced which have
Global HIV Therapeutics Market
The HIV Therapeutics Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. The human immunodeficiency virus (HIV) refers to a type of retrovirus that causes acquired immunodeficiency syndrome (AIDS). HIV attacks some immune cells and causes weakness of immune system resulting in loss
Hidden HIV Revealed: New Insights Into Latent HIV Infections
In spite of ever more effective therapies, HIV keeps managing to survive in the body. A comprehensive project conducted by the Austrian Science Fund FWF has clarified the molecular processes which contribute to this effect. In the process, approaches were discovered for possible therapies to combat the hidden reservoir formed by the virus. Thanks to modern therapies, HIV infections have become controllable – but these treatments cannot provide a cure. Antiretroviral